- Details
- Written by: Administrator
The research team RPQure Neuromedical Genetics recently moved from the Netherlands Institute for Neuroscience (NIN) to the Leiden University Medical Center (LUMC) Department of Ophthalmology. Future clinical gene therapy studies for Retinitis Pigmentosa (RP) and Leber congenital amaurosis (LCA) patients with mutations in the CRB1 gene will be performed at the LUMC Department of Ophthalmology in the Netherlands.
- Details
- Written by: Administrator
Check out this amazing gene therapy video on the Foundation Fighting Blindness website
- Details
- Written by: Administrator
Roche has announced that phase III clinical studies have been initiated for lampalizumab, an investigational drug for geographic atrophy (GA), the advanced form of age-related macular degeneration (AMD).